Arbutus Biopharma Corp

ABUS · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.8B · 19 employees
527
SEC Filings
$5.01
Close 2026-09-18
19
Employees

Business Summary

Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company focused on infectious disease, specifically chronic hepatitis B (cHBV). It develops imdusiran (AB-729), a GalNAc-conjugated subcutaneous RNAi therapeutic, and AB-101, an oral PD-L1 inhibitor, both targeting cHBV functional cure. The company also owns patented lipid nanoparticle (LNP) technology licensed via Genevant Sciences, and is pursuing patent infringement litigation against Pfizer/BioNTech and has settled with Moderna for $950 million noncontingent payment.

Latest Stock Quote

ABUS 2026-09-18 $5.01 O:$5.04 H:$5.06 L:$4.98 Vol:6.5M VWAP:$5.0156
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-07

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-232025-12-310001447028-26-000017EDGAR66K words
2025-03-272024-12-310001447028-25-000083EDGAR66K words
2024-03-052023-12-310001447028-24-000035EDGAR64K words
2023-03-022022-12-310001447028-23-000018EDGAR66K words
2022-03-032021-12-310001447028-22-000019EDGAR—
2021-03-042020-12-310001447028-21-000021EDGAR—
2020-03-052019-12-310001447028-20-000038EDGAR—
2019-03-072018-12-310001447028-19-000006EDGAR—
2018-03-162017-12-310001628280-18-003276EDGAR—
2017-03-222016-12-310001628280-17-002760EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-122026-06-300001447028-26-000045EDGAR24K words
2025-11-132025-09-300001447028-25-000126EDGAR24K words
2025-08-062025-06-300001447028-25-000115EDGAR23K words
2025-05-142025-03-310001447028-25-000099EDGAR22K words
2024-11-062024-09-300001447028-24-000087EDGAR24K words
2024-08-082024-06-300001447028-24-000072EDGAR24K words
2024-05-022024-03-310001447028-24-000038EDGAR23K words
2023-11-072023-09-300001447028-23-000090EDGAR26K words
2023-08-032023-06-300001447028-23-000082EDGAR26K words
2023-05-042023-03-310001447028-23-000025EDGAR25K words
2022-11-092022-09-300001447028-22-000055EDGAR—
2022-08-042022-06-300001447028-22-000047EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-210001104659-26-099390EDGAR1K words
2026-08-120001171843-26-005442EDGAR3K words
2026-07-160001171843-26-004708EDGAR2K words
2026-03-230001171843-26-001838EDGAR3K words
2026-03-030001171843-26-001299EDGAR1K words
2026-02-200001171843-26-000979EDGAR6K words
2026-02-060001171843-26-000676EDGAR11K words
2026-01-160001171843-26-000303EDGAR1K words
2025-12-110001171843-25-007879EDGAR2K words
2025-11-130001171843-25-007256EDGAR3K words

527 total filings indexed. 495 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

chronic-hepatitis-b-(chbv)-treatment rna-interference-(rnai)-therapeutics lipid-nanoparticle-(lnp)-drug-delivery infectious-disease-biopharmaceuticals rna-interference-(rnai) galnac-conjugation lipid-nanoparticle-(lnp)-delivery messenger-rna-(mrna)-delivery pd-l1-inhibition

Company Identity

CIK0001447028
TickerABUS
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedA1
HeadquartersWarminster, Pennsylvania
Websitehttp://www.arbutusbio.com
Listed2007-07-26

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: eaf7f99cfa19612497bc99b03c315a27a24e3179f8bf817f0a0f8246d8f63b5d
parent: e1cb27b008f20f455a003a821b3e70c8e0f0f6e67ae8e385b0ff8f344f369df2
content hash: 8d7cc35d142efff20011d186e363ba4f8befd28a837e9b8c385cc57d62a0f655
signed: 2026-09-29T12:00:06.438Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up ABUS using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on ABUS, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/ABUS (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.